Neumann, J.T.* ; Twerenbold, R.* ; Ojeda, F.* ; Sörensen, N.A.* ; Chapman, A.R.* ; Shah, A.S.V.* ; Anand, A.* ; Boeddinghaus, J.* ; Nestelberger, T.* ; Badertscher, P.* ; Mokhtari, A.* ; Pickering, J.W.* ; Troughton, R.W.* ; Greenslade, J.* ; Parsonage, W.* ; Mueller-Hennessen, M.* ; Gori, T.* ; Jernberg, T.* ; Morris, N.* ; Liebetrau, C.* ; Hamm, C.* ; Katus, H.A.* ; Münzel, T.* ; Landmesser, U.* ; Salomaa, V.* ; Iacoviello, L.* ; Ferrario, M.M.* ; Giampaoli, S.* ; Kee, F.* ; Thorand, B. ; Peters, A. ; Borchini, R.* ; Jørgensen, T.* ; Söderberg, S.* ; Sans, S.* ; Tunstall-Pedoe, H.* ; Kuulasmaa, K.* ; Renné, T.* ; Lackner, K.J.* ; Worster, A.* ; Body, R.* ; Ekelund, U.* ; Kavsak, P.A.* ; Keller, T.* ; Lindahl, B.* ; Wild, P.* ; Giannitsis, E.* ; Than, M.* ; Cullen, L.A.* ; Mills, N.L.* ; Mueller, C.* ; Zeller, T.* ; Westermann, D.* ; Blankenberg, S.*
Application of high-sensitivity troponin in suspected myocardial infarction.
N. Engl. J. Med. 380, 2529-2540 (2019)
BackgroundData regarding high-sensitivity troponin concentrations in patients presenting to the emergency department with symptoms suggestive of myocardial infarction may be useful in determining the probability of myocardial infarction and subsequent 30-day outcomes.MethodsIn 15 international cohorts of patients presenting to the emergency department with symptoms suggestive of myocardial infarction, we determined the concentrations of high-sensitivity troponin I or high-sensitivity troponin T at presentation and after early or late serial sampling. The diagnostic and prognostic performance of multiple high-sensitivity troponin cutoff combinations was assessed with the use of a derivation-validation design. A risk-assessment tool that was based on these data was developed to estimate the risk of index myocardial infarction and of subsequent myocardial infarction or death at 30 days.ResultsAmong 22,651 patients (9604 in the derivation data set and 13,047 in the validation data set), the prevalence of myocardial infarction was 15.3%. Lower high-sensitivity troponin concentrations at presentation and smaller absolute changes during serial sampling were associated with a lower likelihood of myocardial infarction and a lower short-term risk of cardiovascular events. For example, high-sensitivity troponin I concentrations of less than 6 ng per liter and an absolute change of less than 4 ng per liter after 45 to 120 minutes (early serial sampling) resulted in a negative predictive value of 99.5% for myocardial infarction, with an associated 30-day risk of subsequent myocardial infarction or death of 0.2%; a total of 56.5% of the patients would be classified as being at low risk. These findings were confirmed in an external validation data set.ConclusionsA risk-assessment tool, which we developed to integrate the high-sensitivity troponin I or troponin T concentration at emergency department presentation, its dynamic change during serial sampling, and the time between the obtaining of samples, was used to estimate the probability of myocardial infarction on emergency department presentation and 30-day outcomes.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Cardiac Troponin; Rule-out; Early-diagnosis; I Assay; Biomarker; Population; Validation; Algorithm; Outcomes
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2019
Prepublished im Jahr
HGF-Berichtsjahr
2019
ISSN (print) / ISBN
0028-4793
e-ISSN
1533-4406
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 380,
Heft: 26,
Seiten: 2529-2540
Artikelnummer: ,
Supplement: ,
Reihe
Verlag
Massachusetts Medical Society (MMS)
Verlagsort
Waltham Woods Center, 860 Winter St,, Waltham, Ma 02451-1413 Usa
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
Institut(e)
Institute of Epidemiology (EPI)
POF Topic(s)
30202 - Environmental Health
Forschungsfeld(er)
Genetics and Epidemiology
PSP-Element(e)
G-504000-002
Förderungen
Copyright
Erfassungsdatum
2019-07-01